TRENDS IN INCIDENCE AND MORTALITY FROM PANCREATIC CANCER IN CENTRAL SERBIA, IN THE PERIOD FROM 1999 TO 2019
Abstract
Introduction: Pancreatic cancer is the fourteenth leading cause of disease and the seventh leading cause
of death among all malignant diseases. The aim of the research was to analyze the trends in the incidence
and death of pancreatic cancer in central Serbia for the period 1999-2019. years.
Methods: The data about diseased and dead, as well as population by sex and age, in the period 1999-
2015 were taken over from the Cancer registry of Central Serbia, and the data for 2016, 2017, 2018 and
2019 were obtained from the Institute of Public Health of Serbia. Based on obtained data, we counted
crude, specific and standardized rates of incidence and mortality for pancreatic cancers, for all ages.
Trends rate in incidence and mortality were counted using joinpoint regression analysis.
Results: In the period 1999-2019. In central Serbia, the average annual number of patients was 378 men
and 305 women, and the average number of deaths was 406 men and 336 women. The average annual
standardized incidence rate (per 100,000) was 7.7 for men and 5.0 for women, and the standardized
mortality rate (per 100,000) was 7.9 for men and 5.1 for women. In men, the highest average annual agespecific incidence rate was recorded at the age of 60-69 (39.7 per 100,000), and the mortality rate at the
age of 70 and over (42.4 per 100,000). Among women, the highest incidence and mortality rates were in
the oldest age (70 and over) and were 25.7 and 34.8 per 100,000. During the observed period, there was
a significant increase in standardized incidence rates for men of 2.9% and for women of 3.7% per year.
Also, a trend of increasing standardized mortality rates was observed in men (of 1.2%) and women (of
0.6%), but significance was achieved only in men.
Conclusion: In the period 1999-2019. in central Serbia, incidence and mortality rates are on the rise.
Research on risk factors for the development of this disease is necessary in order to take preventive
measures. Also, early detection and timely therapy should contribute to the reduction of death from this
malignancy
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin 2021; 71(3):209–49.
2. Rawla P, Sunkara T, Gaduputi V. Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors. World J Oncol 2019; 10(1):10–27.
3. Hassan MM, Abbruzzese JL, Evans B, Li D. Risk Factors for Pancreatic Cancer: Case-Control Study. Am J Gastroenterol 2007; 102(12): 2696–707.
4. Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the
UK in 2010: Summary and conclusions. Br J Cancer 2011; 105(S2):S77–81.
5. Larsson SC, Permert J, Håkansson N, Näslund I, Bergkvist L, Wolk A. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 2005; 93(11):1310–5. 6. Lowenfels AB. Epidemiology and Prevention of Pancreatic Cancer. Jap J Clin Oncol 2004; 34(5):238–44.
7. Hidalgo M. Pancreatic Cancer. N Engl J Med 2010; 362(17):1605–17.
8. Huang J, Lok V, Ngai CH, Zhang L, Yuan J, Lao XQ, et al. Worldwide Burden of, Risk Factors for, and Trends in
Pancreatic Cancer. Gastroenterology 2021; 160(3):744–54.
9. Sant M, Aareleid T, Berrino F, Bielska Lasota M, Carli PM, Faivre J, et al. EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary. Ann Oncol 2003; 14:v61–118.
10. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Sendai, Japan: Department of Public Health, Tohoku University of Medicine; 1960. 11. Kim H-J, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine 2000; 17.
12. Lerman PM. Fitting Segmented Regression Models by Grid Search. Applied Statistics 1980; 29(1):77.
13. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJL, Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360(9343):1347–60.
14. Jarosz M, Sekuła W, Rychlik E. Influence of Diet and Tobacco Smoking on Pancreatic Cancer Incidence in Poland in 1960–2008. Gastroenterol Res Pract 2012;2012:682156.
15. Flook R, van Zanten SV. Pancreatic Cancer in Canada: Incidence and Mortality Trends from 1992 to 2005.
Can J Gastroenterology 2009;23(8):546–50.
16. Chen W-Q, Liang D, Zhang S-W, Zheng R-S, He Y-T. Pancreatic Cancer Incidence and Mortality Patterns in
China, 2009. Asian Pac J Cancer Prev 2013;14(12):7321–4.
17. World Health Organization. International Agency for Research on Cancer.13-Pancreas-fact-sheet.pdf. The
Global Cancer Observatory. Available at: https://gco.iarc.fr/today/data/factsheets/cancers/13-Pancreas-fact-sheet.pdf
18. Oberstein PE, Olive KP. Pancreatic cancer: why is it so hard to treat? Therap Adv Gastroenterol 2013; 6(4):321–37.
19. Kuzmickiene I, Everatt R, Virviciute D, Tamosiunas A, Radisauskas R, Reklaitiene R, et al. Smoking and other risk factors for pancreatic cancer: A cohort study in men in Lithuania. Cancer Epidemiology 2013;37(2):133–9.
20. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg 2008; 393(4):535–45.
21. Institut za javno zdravlje “dr Milan Jovanović Batut”. Istraživanje zdravlja stanovništva Srbije 2019.
Beograd,2021. [Internet]. [cited 2022 Mar 10]. Available from: https://www.batut.org.rs/download/publikacije/
ZdravljeStanovnistva2019.pdf
22. Luo J, Adami H-O, Reilly M, Ekbom A, Nordenvall C, Ye W. Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960–2003). Cancer Causes Control 2008;19(1):89–96.